Citigroup’s PepperLime Health Acquisition Corporation Class A Ordinary Share PEPL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-125,433
Closed -$1.28M 5958
2022
Q4
$1.28M Hold
125,433
﹤0.01% 2395
2022
Q3
$1.25M Buy
+125,433
New +$1.25M ﹤0.01% 2538

Other funds holding PEPL

Citigroup's PEPL Position: Q1 2023 in Review

Citigroup sold out of PepperLime Health Acquisition Corporation Class A Ordinary Share (PEPL) in Q1 2023, closing a stake of 125,433 shares — an estimated $1.28M sold.

Citigroup first reported a position in PEPL in Q3 2022 and held it in 2 quarters. The position peaked at $1.28M in Q4 2022. 15 funds tracked by Wall St. Rank hold PEPL as of Q1 2023.

  • Citigroup reported no remaining PepperLime Health Acquisition Corporation Class A Ordinary Share position as of Q1 2023 after selling out during the quarter.
  • Citigroup sold 125,433 PepperLime Health Acquisition Corporation Class A Ordinary Share shares in Q1 2023, an estimated $1.28M.
  • Citigroup first reported a position in PepperLime Health Acquisition Corporation Class A Ordinary Share in Q3 2022 and held it in 2 quarters.
  • Citigroup's PepperLime Health Acquisition Corporation Class A Ordinary Share position peaked at $1.28M in Q4 2022.
  • 15 funds tracked by Wall St. Rank held PepperLime Health Acquisition Corporation Class A Ordinary Share as of Q1 2023.

Based on Citigroup's 13F filing for Q1 2023, filed 11 May 2023.